SMARCA4 and non-small cell lung carcinoma: Prior studies have classified mutations associated with SMARCA4-deficient NSCLC into 2 categories: Type 1 mutations, encompassing truncating mutations, homozygous deletions, or fusion mutations, and Type 2 mutations, characterized by missense mutations and non-truncating alterations with preserved protein expression.